These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Medical treatment of Barrett's esophagus: can it prevent cancer? Sampliner RE Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739 [TBL] [Abstract][Full Text] [Related]
28. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Achkar E; Carey W Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739 [TBL] [Abstract][Full Text] [Related]
29. [Esophagoscopic monitoring of Barrett's esophagus--additional life years of good quality or wasting of limited resources?]. Voutilainen M Duodecim; 2010; 126(5):507-14. PubMed ID: 20597303 [TBL] [Abstract][Full Text] [Related]
30. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma. Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246 [No Abstract] [Full Text] [Related]
31. Barrett's esophagus and cytokine polymorphisms-confusion about the content in the abstract/results section compared to the table given in a recent manuscript. Leodolter A Am J Gastroenterol; 2005 Dec; 100(12):2814. PubMed ID: 16393242 [No Abstract] [Full Text] [Related]
32. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Corey KE; Schmitz SM; Shaheen NJ Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338 [TBL] [Abstract][Full Text] [Related]
33. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study. Lassen A; Hallas J; de Muckadell OB Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936 [TBL] [Abstract][Full Text] [Related]
34. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028 [TBL] [Abstract][Full Text] [Related]
35. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Provenzale D; Schmitt C; Wong JB Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526 [TBL] [Abstract][Full Text] [Related]
36. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322 [TBL] [Abstract][Full Text] [Related]
37. Meta analysis: Cancer risk in Barrett's oesophagus. Thomas T; Abrams KR; De Caestecker JS; Robinson RJ Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1465-77. PubMed ID: 17900269 [TBL] [Abstract][Full Text] [Related]
38. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156 [TBL] [Abstract][Full Text] [Related]
39. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia. Donnellan F; Harewood GC; Patchett SE Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322 [No Abstract] [Full Text] [Related]